Table 2 Demographics and clinical characteristics of groups classified by type of CAD
From: Predictive ability of EuroSCORE II integrating cardiactroponin T in patients undergoing OPCABG
Variables | Stable group (n = 599) | Unstable group (n = 1028) | AMI group (n = 260) | P |
|---|---|---|---|---|
Age (y) | 64.62 (59;71) | 65.34 (61;71) | 64.06 (59;70) | 0.052 |
Female (n, %) | 119 (19.9) | 278 (27.0) | 63 (24.2) | 0.005 |
Weight (kg) | 69.45 (62;76) | 68.75 (60;75) | 68.11 (61;74) | 0.154 |
Height (cm) | 167.12 (162.00;172.00) | 166.15 (160.00;171.00) | 166.60 (160.25;171.75) | 0.053 |
BMI (kg/m2) | 24.83 (22.89;26.84) | 24.85 (22.84;26.77) | 24.49 (22.54;25.92) | 0.105 |
BSA (m2) | 1.76 (1.64;1.87) | 1.74 (1.62;1.85) | 1.74 (1.63;1.83) | 0.155 |
Diabetes (n, %) | 149 (24.9) | 352 (34.2) | 89 (34.2) | 0.000 |
Hypertention (n, %) | 364 (60.8) | 743 (72.3) | 184 (70.8) | 0.000 |
Cr (μmol/l) | 83.25 (64.60;90.20) | 81.82 (64.50;89.58) | 83.02 (67.78;91.73) | 0.164 |
Ccr (mL/min/1.73 m2) | 82.28 (65.12;91.06) | 81.12 (62.53;95.94) | 79.14 (62.35;90.86) | 0.076 |
Renal failure (n, %) | 7 (1.2) | 17 (1.7) | 5 (1.9) | 0.642 |
Myocardial injury classification | Â | Â | Â | 0.000 |
 Stage 1 (n, %) | 414 (69.1) | 767 (74.6) | 141 (54.2) |  |
 Stage 2 (n, %) | 160 (26.7) | 217 (21.1) | 78 (30.0) |  |
 Stage 3 (n, %) | 9 (1.5) | 17 (1.7) | 19 (7.3) |  |
 Stage 4 (n, %) | 16 (2.7) | 27 (2.6) | 22 (8.5) |  |
Cerebrovascular disease (n, %) | 81 (13.5) | 221 (21.5) | 48 (18.5) | 0.000 |
COPD (n, %) | 18 (3.0) | 27 (2.6) | 9 (3.5) | 0.746 |
Peripheral vascular disease (n, %) | 17 (2.8) | 23 (2.2) | 7 (2.7) | 0.736 |
Previous PCI (n, %) | 22 (3.7) | 76 (7.4) | 17 (6.5) | 0.010 |
Atrial flutter and fibrillation (n, %) | 14 (2.3) | 40 (3.9) | 12 (4.6) | 0.148 |
Combined valvulardisease (n, %) | 138 (23.0) | 67 (6.5) | 44 (16.9) | 0.000 |
Pulmonary hypertension (n, %) | 69 (11.6) | 83 (8.1) | 27 (10.4) | 0.063 |
Number of diseased vessels (n) | 2.84 (3;3) | 2.85 (3;3) | 2.87 (3;3) | 0.683 |
NYHA | Â | Â | Â | 0.000 |
 I (n, %) | 68 (11.4) | 109 (10.6) | 40 (15.4) |  |
 II (n, %) | 402 (67.1) | 691 (67.2) | 136 (52.3) |  |
 III (n, %) | 122 (20.4) | 212 (20.6) | 70 (26.9) |  |
 IV (n, %) | 7 (1.2) | 16 (1.6) | 14 (5.4) |  |
LVEF (%) | 61.45 (60.10;65.60) | 61.32 (60.00;65.78) | 58.09 (52.27;64.40) | 0.000 |
EuroSCORE II | 1.44 (1.21;1.79) | 1.73 (0.95;2.10) | 2.02 (0.96;2.47) | 0.000 |
Bypass graft number (n) | 3.69 (3;4) | 3.44 (3;4) | 3.60 (3;4) | 0.000 |
In-hospital mortality (n, %) | 14 (2.3) | 19 (1.8) | 10 (3.8) | 0.155 |